0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence |

Neuroendocrine Liver Metastasis: Transplant as Part of Multimodality Liver-Directed Therapy

Skye C. Mayo, MD, MPH; Andrew M. Cameron, MD, PhD; Timothy M. Pawlik, MD, MPH
Arch Surg. 2012;147(1):98-99. doi:10.1001/archsurg.147.1.98.
Text Size: A A A
Published online

Extract

We read with great interest the recent article by Gedaly et al1 regarding the role of liver transplantation for patients with metastatic neuroendocrine tumors. The authors used the United Network for Organ Sharing database to identify 150 patients with metastatic neuroendocrine tumors out of 87 280 patients who underwent a liver transplant during the 10-year period from 1998 to 2008. During the same period, Gedaly et al1 compared the survival of patients who underwent a transplant for neuroendocrine liver metastasis (NELM) with the survival of patients who underwent a transplant for hepatocellular carcinoma. They reported 1-, 3-, and 5-year survival rates of 81%, 65%, and 49%, respectively, for the 137 patients who underwent an isolated liver transplant for NELM. On bivariate analyses, the authors did not note a difference in survival following a transplant for patients with NELM compared with patients with hepatocellular carcinoma (P = .20). The authors concluded that a transplant for unresectable NELM disease is indicated in patients with a stable disease without disseminated metastases.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

January 1, 2012
Roberto Gedaly, MD; Michael F. Daily, MD; Daniel L. Davenport, MD; Patrick P. McHugh, MD; Paul Angulo, MD; Jonathan C. Hundley, MD
Arch Surg. 2012;147(1):99. doi:10.1001/archsurg.147.1.99.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

3 Views
0 Citations
×

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Articles Related By Topic
Related Collections
PubMed Articles
[Neuroendocrine pancreatic carcinoma]. Dtsch Med Wochenschr 2007;132(43):2284; author reply 2284.
Jobs
brightcove.createExperiences();